MELANOMA STAGE III OR IV
Clinical trials for MELANOMA STAGE III OR IV explained in plain language.
Never miss a new study
Get alerted when new MELANOMA STAGE III OR IV trials appear
Sign up with your email to follow new studies for MELANOMA STAGE III OR IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental antibody trio takes on Hard-to-Treat melanoma
Disease control OngoingThis early-phase trial tests a new experimental antibody called BI-1607 alongside two existing immunotherapies (ipilimumab and pembrolizumab) in 35 people with advanced melanoma that has spread or cannot be removed. The goal is to see if the combination is safe and can shrink tum…
Matched conditions: MELANOMA STAGE III OR IV
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Melanoma survivors: could immunotherapy harm your heart years later?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether melanoma patients who received immunotherapy might have heart problems years later. Researchers will invite 60 people who finished treatment 2 to 10+ years ago to undergo heart tests. The goal is to see if it's possible to study these long-term side ef…
Matched conditions: MELANOMA STAGE III OR IV
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC